Aditxt, Inc. Deferred Tax Assets, Gross
Aditxt, Inc. (ADTX) had Deferred Tax Assets, Gross of $44.78 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Gross $44.78M.
- 2024-12-31: Deferred Tax Assets, Gross $34.96M; Deferred Tax Assets, Gross as first filed $34.96M.
- 2023-12-31: Deferred Tax Assets, Gross $27.04M.
- 2022-12-31: Deferred Tax Assets, Gross $21.11M.
| Period end | Deferred Tax Assets, Gross | Deferred Tax Assets, Gross as first filed |
|---|---|---|
| 2025-12-31 | $44.78M 10-K · filed 2026-03-31 | |
| 2024-12-31 | $34.96M 10-K · filed 2026-03-31 | $34.96M 10-K · filed 2025-03-31 |
| 2023-12-31 | $27.04M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $21.11M 10-K · filed 2024-04-16 | |
| 2021-12-31 | $17.93M 10-K · filed 2023-04-17 | |
| 2020-12-31 | $6.49M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $2.02M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |